LDS/Medical Tests/Complement Component CH50

Complement Component CH50

The complement system is a group of soluble and cell-surface proteins whose function is to recognize, opsonize (label), and alter host cells to destroy and clear invading microorganisms and cancer cells. Complement is a major part of the innate immune system and can be activated via the classical and the alternative routes. The classic pathway is usually activated by antigen-antibody and cell antibody complexes. The alternate pathway is activated by foreign pathogens such as bacteria, fungi, and some immune complexes. Activation of the classic pathway involves a complex of complement proteins including C1, C4, C2, C3, and C5 to C9. In the alternate pathway, activation of C1, C4, and C2 are bypassed and C3 is activated by an initiating factor (IF), and two substances called properdin Factors D and properdin factor B. Since the function of these proteins is to label and eliminate foreign and cancerous cells, an increase in complement protein levels is an acute phase reaction with normalization thereafter.

In this test, red blood cells (classically from sheep, but others may be in use) are coated with antibody. A complement source (serum, synovial fluid, etc) is added with magnesium and calcium. The degree of hemolysis is measured quantitatively and compared with standard controls.

The main clinical use of the CH50 assay is the detection of decreased levels, which may indicate an ongoing immunological disorder. A normal hemolytic complement component or CH50 assay level indicates that all the classical complement components, C1 through C9, are present in sufficient amount. However, in some cases the individual complement factors may be significantly decreased without affecting CH50 activity since some components are present in excess. For this reason, in addition to CH50, it may be necessary to measure individual complement component levels. C3 protein is the key molecule in both the classical and alternative pathways and is present in the highest concentration. Decreased levels of both C3 and C4 indicate classical pathway activation. Decreased C3 levels with normal C4 levels indicate alternate pathway activation. Very low or undetectable levels of C4 with normal or relatively normal levels of C3 are often seen in type II cryoglobulinemia, which is most commonly associated with hepatitis C infection. Generally, decreased levels of individual complement proteins are due to increased utilization of these proteins. Because synthesis of complement proteins increases with inflammatory disease, normal levels do not prove that the complement sequence is not involved in tissue injury. Decreased levels of the CH50 are seen in systemic lupus erythematosus (SLE), glomerulonephritis, and other immune complex diseases. Decreased CH50 titers and complement protein levels may be seen in the joint fluid of patients with rheumatoid arthritis, gout, pseudogout, Reiter’s syndrome, and gonococcal arthritis. Serum levels of other complement proteins in these patients may be normal or increased.

  • As an aid in diagnosis of recurrent microbial infections, angioedema, or inflammation
  • As an aid in diagnosis and monitoring the activity of acute or chronic autoimmune diseases such as systemic lupus erythematosus (SLE)
  • Diagnosis of Complement Component C3 congenital deficiency

Decreased in:

  • Classic pathway complement component congenital or acquired deficiencies
  • Systemic lupus erythematosus (SLE)
  • Glomerulonephritis and other immune complex diseases

Normal in:

  • Deficiencies of the alternative pathway complement components
Specimen U/mL kU/L
Serum 33-61 33-61

Normal synovial, pleural, or CNS fluid complement470% of serum complement after correction for protein:

Fluid C . Fluid Protein x100
Serum C . Serum Protein  

Synovial fluid: >=33% of matching serum CH50.5

Quantitative hemolysis (total complement hemolytic activity). 

Serum (SST). 

Stability

  • Ambient: Unacceptable
  • Refrigerated: Unacceptable
  • Frozen: 30 days
  • Centrifuge within 60 minutes of collection. Keep sample frozen until testing.
Complement component 4 and 3, Antibody Tests, ESR, CRP, RF, ANA, anti-DNA, CMP.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login